# Vertex Pharmaceuticals Inc / Ma: Form DEF 14A, filed Apr 7, 2022

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: DEF 14A
- Filed: 2022-04-07
- Accepted by EDGAR: Apr 7, 2022, 16:05 ET
- Period: 2022-05-18
- Accession: 0001308179-22-000210
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000130817922000210/lvrtx2022_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000130817922000210/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000130817922000210/lvrtx2022_def14a.htm

Filed Apr 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001308179-22-000210. Last ingested by Listed: Nov 12, 2026, 21:33 ET. No prices; not investment advice.